Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
Hepatocellular carcinoma (HCC) ranks as a leading cause of common cancer and cancer-related death. The major etiology of HCC is due to chronic hepatitis virus including HBV and HCV infections. Scheduled HCC surveillance in high risk populations improves the early detection rate and the feasibility o...
Main Authors: | Wei Teng, Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Su |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1729 |
Similar Items
-
Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
by: Faydra I. Lieveld, et al.
Published: (2013-05-01) -
Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study
by: Yi-Cheng Chen, et al.
Published: (2020-05-01) -
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
by: Piero Colombatto, et al.
Published: (2022-03-01) -
Lamivudine: fading into the mists of time
by: Jonggi Choi, et al.
Published: (2017-12-01) -
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
by: Chih-Lang Lin, et al.
Published: (2023-06-01)